F&E, Pharmakovigilanz & Regulatory Affairs

F&E, Pharmakovigilanz & Regulatory Affairs

Forschung, Entwicklung, Testung und Einführung neuer Arzneimittel. Der Entwicklungsprozess dauert 8 bis 10 Jahre und besteht aus 4 Phasen.

  • F&E, Pharmakovigilanz & Regulatory Affairs

    Forschung, Entwicklung, Testung und Einführung neuer Arzneimittel. Der Entwicklungsprozess dauert 8 bis 10 Jahre und besteht aus 4 Phasen.

Stellenbezeichnung Sort ascending Standort Datum Req ID
Zurücksetzen
Clinical Operations Excellence Manager
Clinical Operations Excellence Manager Parma, IT 25.06.2025 5834
Parma, IT 25.06.2025 5834
Clinical Program Leader
Clinical Program Leader Parma, IT 27.06.2025 5447
Parma, IT 27.06.2025 5447
Clinical Research Physician COPD/Bronchiectasis Parma, IT 27.06.2025 5450
Clinical Trial Administrator - Maternity leave
Clinical Trial Administrator - Maternity leave Flexible, IT 06.06.2025 5768
Flexible, IT 06.06.2025 5768
Modeling & Simulation Scientist
Modeling & Simulation Scientist Parma, IT 23.06.2025 5264
Parma, IT 23.06.2025 5264
Principal Extractable and Leachable Scientist Parma, IT 15.06.2025 5557
Real World Evidence Lead Pharmacoepidemiologist
Real World Evidence Lead Pharmacoepidemiologist Europe Remote, IT 13.06.2025 5661
Europe Remote, IT 13.06.2025 5661
Regulatory Affairs & Pharmacovigilance Officer Lahore, PK 16.06.2025 5806
Regulatory Affairs CMC Specialist - Contract
Regulatory Affairs CMC Specialist - Contract Boston, MA, US 14.06.2025 5655
Boston, MA, US 14.06.2025 5655
Senior Clinical Project Manager
Senior Clinical Project Manager Cary, NC, US 13.06.2025 5797
Cary, NC, US 13.06.2025 5797
Senior Clinical Research Physician Non-Obstructive Respiratory Diseases Parma, IT 27.06.2025 5448
Senior Global Regulatory Affairs Project Manager Parma, IT 11.06.2025 5787
Sr. Director, R&D External Opportunities
Sr. Director, R&D External Opportunities Parma, IT 25.06.2025 5830
Parma, IT 25.06.2025 5830